A significant increase in the C−O stretching force constant (F CO) and a decrease in C−O bond length (r CO) result upon coordination of carbon monoxide to various cationic species. We report a study designed to elucidate the factors responsible for this effect. In particular, we distinguish between an explanation based on electrostatic effects and one based on withdrawal of electron density from the 5σ orbital of CO, an orbital generally considered to have some antibonding character. Ab initio electronic structure calculations on CO in the presence of a positive point charge (located on the carbon side of the bond axis) reveal that a simple Coulombic field increases the C−O stretching force constant and decreases the bond length. Coordination of CO to a simple cationic Lewis acid such as H+ or CH3 + is calculated to increase F CO (and decrease r CO) to extents slightly less than those engendered by a point charge at the same distance from the carbonyl carbon. These results indicate that electron donation from the 5σ orbital has no intrinsic positive effect on the magnitude of F CO. Calculations were also conducted on several symmetrical, neutral, and cationic transition metal complexes, including some examples of the recently discovered homoleptic noble-metal carbonyls. It is found that F CO values can be quantitatively interpreted using a model which invokes only the effects of M−CO π-back-bonding and an electrostatic parameter. There is no correlation between the extent of σ-bonding (as measured by the depopulation of the CO σ orbitals) and F CO. Calculations on trigonal bipyramidal d8 metal pentacarbonyls permit a comparison between inequivalent ligands (axial and equatorial) which, being coordinated to the same metal center, must experience approximately the same electrostatic field. In the case of Ru(CO)5, π-back-bonding to the axial and equatorial carbonyls is of virtually equal magnitude, while σ-donation is much greater from the axial ligands than from the equatorial ligands. Nevertheless, the F CO and r CO values of the two ligand sets are essentially equal, confirming that the magnitude of σ-donation does not affect these parameters.

The p-methoxy-substituted pincer-ligated iridium complexes, (MeO-(tBu)PCP)IrH(4) ((R)PCP = kappa(3)-C(6)H(3)-2,6-(CH(2)PR(2))(2)) and (MeO-(iPr)PCP)IrH(4), are found to be highly effective catalysts for the dehydrogenation of alkanes (both with and without the use of sacrificial hydrogen acceptors). These complexes offer an interesting comparison with the recently reported bis-phosphinite "POCOP" ((R)POCOP = kappa(3)-C(6)H(3)-2,6-(OPR(2))(2)) pincer-ligated catalysts, which also show catalytic activity higher than unsubstituted PCP analogues (Gottker-Schnetmann, I.; White, P.; Brookhart, M. J. Am. Chem. Soc. 2004, 126, 1804). On the basis of nu(CO) values of the respective CO adducts, the MeO-PCP complexes appear to be more electron-rich than the parent PCP complexes, whereas the POCOP complexes appear to be more electron-poor. However, the MeO-PCP and POCOP ligands are calculated (DFT) to show effects in the same directions, relative to the parent PCP ligand, for the kinetics and thermodynamics of a broad range of reactions including the addition of C-H and H-H bonds and CO. In general, both ligands favor (relative to unsubstituted PCP) addition to the 14e (pincer)Ir fragments but disfavor addition to the 16e complexes (pincer)IrH(2) or (pincer)Ir(CO). These kinetic and thermodynamic effects are all largely attributable to the same electronic feature: O --> C(aryl) pi-donation, from the methoxy or phosphinito groups of the respective ligands. DFT calculations also indicate that the kinetics (but not the thermodynamics) of C-H addition to (pincer)Ir are favored by sigma-withdrawal from the phosphorus atoms. The high nu(CO) value of (POCOP)Ir(CO) is attributable to electrostatic effects, rather than decreased Ir-CO pi-donation or increased OC-Ir sigma-donation.

No abstract

No abstract

The rapid emergence of drug-resistant variants of human immunodeficiency virus, type 1 (HIV-1), has limited the efficacy of anti-acquired immune deficiency syndrome (AIDS) treatments, and new lead compounds that target novel binding sites are needed. We have determined the 3.15 Å resolution crystal structure of HIV-1 reverse transcriptase (RT) complexed with dihydroxy benzoyl naphthyl hydrazone (DHBNH), an HIV-1 RT RNase H (RNH) inhibitor (RNHI). DHBNH is effective against a variety of drug-resistant HIV-1 RT mutants. While DHBNH has little effect on most aspects of RT-catalyzed DNA synthesis, at relatively high concentrations it does inhibit the initiation of RNAprimed DNA synthesis. Although primarily an RNHI, DHBNH binds >50 Å away from the RNH active site, at a novel site near both the polymerase active site and the non-nucleoside RT inhibitor (NNRTI) binding pocket. When DHBNH binds, both Tyr181 and Tyr188 remain in the conformations seen in unliganded HIV-1 RT. DHBNH interacts with conserved residues (Asp186, Trp229) and has substantial interactions with the backbones of several less well-conserved residues. On the basis of this structure, we designed substituted DHBNH derivatives that interact with the NNRTI-binding pocket. These compounds inhibit both the polymerase and RNH activities of RT.Human immunodeficiency virus, type 1 (HIV-1), reverse transcriptase (RT) is essential for HIV replication. RT converts the single-stranded viral genomic RNA into a linear doublestranded DNA that can be integrated into the host chromosomes (reviewed in ref 1). The enzyme has two activities, (i) a DNA polymerase that can use either RNA or DNA as a template and (ii) an RNase H (RNH) that selectively degrades the RNA strand of an RNA-DNA heteroduplex. The RNH activity of RT is required for virus replication; cellular RNH cannot substitute for the retroviral enzyme (2). The RNH activity degrades the genomic RNA during first-strand ("minus-strand") DNA synthesis, which allows the newly synthesized DNA to be used as a template for second-strand ("plus-strand") DNA synthesis.HIV-1 RT is a heterodimer consisting of 66 kDa (p66) and 51 kDa (p51) subunits. The two polypeptide chains have 440 N-terminal amino acid residues in common. These comprise four polymerase subdomains: the thumb, palm, fingers, and connection (3,4). The C-terminus of p66 contains an additional 120 amino acid residues that form the bulk of the RNH domain. Despite having identical N-terminal sequences, the arrangement of the subdomains in the two subunits differs dramatically. The p66 subunit contains a large cleft formed by the fingers, palm, and thumb subdo-mains that can accommodate double-stranded nucleic acid templateprimers (3-6). Although the p51 subunit contains the same four subdomains, it does not form a nucleic acid binding cleft.Because of its pivotal role in the HIV life cycle, HIV RT is a primary target for antiretroviral agents. All RT inhibitors currently approved for the treatment of acquired immune deficiency syndrome (AIDS) inhibit...